| Term 
 
        | H2 Receptor antagonist antacids |  | Definition 
 
        | Indication: hyperacidity: peptic ulcers, GERD   Mechanism of action: blocks the H2 receptor of acid-producing parietal cells making them less responsive to histamine   Drugs: 
Gaviscon(aluminum carbonate and hydroxide salt)
Mylanta(aluminum hydroxide and magnesium hydroxide)
Alka-Seltzers(sodium bicarbonate salt)
milk of magnesia(magnesium hydroxide)
Tums(calcium carbonate)
Pecid(famotidine)
Zantac(ranitidine)
Tagamet(cimetidine) |  | 
        |  | 
        
        | Term 
 
        |   Proton Pump Inhibitor antacids |  | Definition 
 
        | Indication: duodenal ulcers, NSAID induced ulcers, poor response to H2 receptor antagonist   Mechanism of action: inhibit the activity of proton pumps and are used to inhibit gastric acid secretion     Drugs: 
Prilosec (omperazole)
Prevacid (lansoprazole)
Protonix (pantoprazole |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indication: for milder cases of diarrhea   Mechanism of action: coats the wall of the GI tract and absorbs bacteria   Drugs: |  | 
        |  | 
        
        | Term 
 
        | Antidiarrheal antichlolinergic |  | Definition 
 
        | Indication:severe cases of diarrhea   Mechanism of action: work to slowly peristalsis by reducing rhymin contractions and smooth muscle tone of the GI tract     Drug |  | 
        |  | 
        
        | Term 
 
        | Antidiarrheal Intestinal flora modifiers |  | Definition 
 
        | Indication: patients with antibiotic-induced diarrhea   Mechanism of action:work by replinishing the body's normal bacteria flora that causes diarrhea   Drug: |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indication: severe cases of diarrhea   Mechanism of action: reduces bowel motility and reduction of pain associated with diarrhea by relief of rectal spasms   Drug: |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indication:acute and chronic constipation, irritable bowel syndrome   Mechanism of action:absorbs water into the intestines which increases the bulk and distends the bowel to intiate reflex bowel activity=bowel movement     Drugs: |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indication:acute and chronic constipation, fecal impaction   Mechanism of action: "stool softeners" work by lowering the surface tension of the GI fluids so the more water and fat are absorbed through the stools   "lubricant laxatives" work by lubricating fecal material and the intestinal wall     Drugs: 
Colace (docusate sodium)
Fleet Oil (mineral oil) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indication:chronic constipation, bowel prep for surgery   Mechanism of action:work by increasing fecal water content, which results in distention, increase peristalsis and evacuation.     Drugs: |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indication: acute constipation, bowel prep for surgery   Mechanism of action: stimulates the nerves the innervate the intestines also increase fluid in the colon   Drugs: 
Dulcolax (bisacodyl)
Senokot (senna) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indication:replacement hormone therapy   Mechanism of action:augment or antagonize the natural effects of the pituitary hormones   Drugs: 
Cortrosyn (cosyntropin)-cortisol secretion hormone
Humatrope (somatotropin)-growth hormone
Thyrogen (thyrotropin)-thyroid hormone |  | 
        |  | 
        
        | Term 
 
        | Pituitary drugs posterior |  | Definition 
 
        | Indication:excessive thirst, polyuria, and dehydration   Mechanism of action: mimic action of naturally occuring antidiuretic hormone affecting renal water conservation (ADH) reducing water excretion   Drugs: 
Pitressin (vasopressin)
Stimate (desmopressin) |  | 
        |  | 
        
        | Term 
 
        | Thyroid replacement hypothyroidism |  | Definition 
 
        | Indication: euthyroid   Mechanism of action: work to induce changes in the metablic rate incl. protein, carbohydrate and lipid metabolism and axygen consumption, body temp., cellular growth   Drugs: 
T4 (levothyroxine)
T3 (liothyronine)
T3 & T4 (liotrix) |  | 
        |  | 
        
        | Term 
 
        | Antithyroid drugs hyperthyroidism |  | Definition 
 
        | Indication:hyperthyroidism   Mechanism of action: work by inhibiting the incorporation of iodine molecules into the amino acid tyrosine -impede the formation of thyroid hormone   Drugs: |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indication:type 1 and type 2 diabetes   Mechanism of action:serves to replace the insulin that is either not made at all or is made defectively in the body of a diabetic patient   Drugs: 
Humulin R (regular insulin)- short acting
Lantus (insulin glargine)- long acting 
Novolog (insulin aspart)-rapid acting
Humalog (insulin lispro)-rapid acting |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indication:type 2 diabetes mellitus   Mechanism of action: works by decreasing glucose production by the liver   Drugs: |  | 
        |  | 
        
        | Term 
 
        | Antidiabetics sulfonylureas |  | Definition 
 
        | Indication:type 2 diabetes patients who's A1C levels remain elevated after metformin is taken   Mechanism of action: bind to specific receptors in beta cells in the pancreas to stimulate the release of insulin   Drugs: |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Indication:type 2 diabetes   Mechanism of action: increase insulin secretion from the pancreas shorter duration than sulfonylureas   Drugs: 
Prandin (repaglinide)
Starlix (nateglinide) |  | 
        |  | 
        
        | Term 
 
        | Antidiabetic thiazolidinediones |  | Definition 
 
        | Indication:management of type 2 diabetes   Mechanism of action: work by decreasing insulin resistance by enhancing the sensitivity of insulin receptors   Drugs: 
Actos (pioglitazone)
Avandia (rosiglitazone) |  | 
        |  | 
        
        | Term 
 
        | Antidiabetic alpha-glucosidase inhibitors |  | Definition 
 
        | Indication: treat type 2 diabetes   Mechanism of action: work by reversibly inhibiting the enzyme alpha-glucosidase that is found in the small intestines   Drugs: 
Precose (acarbose)
Glyset (miglitol) |  | 
        |  | 
        
        | Term 
 
        | Antidiabetic drug amylin mimetics |  | Definition 
 
        | Indication:type 1 or  type 2 diabetes patients receiving meal time insulin without optimal glucose control   Mechanism of action: work by mimicking the action of the natural hormone amylin   Drugs: |  | 
        |  | 
        
        | Term 
 
        | Antidiabetic drug incretin mimetics |  | Definition 
 
        | Indication:type 2 diabetes patients who have been unable to acheive blood glucose control with metformin, a sulfonylurea and/or glitazone   Mechanism of action: work by stimulating the release of the body's natural insulin in response to high sugar levels after a meal-lowering blood sugar   Drugs: 
Byetta (exenatide)
Januvia (sitagliptin) |  | 
        |  |